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Edited by Felix WielandAbstract Aftiphilin was identiﬁed through a database search
for proteins containing binding motifs for the c-ear domain of
clathrin adaptor protein 1 (AP-1). Here, we demonstrate that
aftiphilin is expressed predominantly in brain where it is enriched
on clathrin-coated vesicles. In addition to eight c-ear-binding
motifs, aftiphilin contains two WXXF-acidic motifs that mediate
binding to the a-ear of clathrin adaptor protein 2 (AP-2) and
three FXXFXXF/L motifs that mediate binding to the a- and
b2-ear. We demonstrate that aftiphilin uses these motifs for
interactions with AP-1 and AP-2 and that it immunoprecipitates
these APs but not AP-3 or AP-4 from brain extracts. Aftiphilin
demonstrates a brefeldin A sensitive localization to the trans-
Golgi network in hippocampal neurons where it co-localizes with
AP-1. Aftiphilin is also found at synapses where it co-localizes
with synaptophysin and AP-2. Our data suggest a role for aftiph-
ilin in clathrin-mediated traﬃcking in neurons.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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At the trans-Golgi network (TGN), clathrin-coated vesicles
(CCVs) mediate the transport of cargo proteins from the secre-
tory pathway to the endosomal/lysosomal system [1]. Central
to this process is the heterotetrameric adaptor protein 1 (AP-
1), composed of c-, b1-, l1- and r1-adaptins [2,3]. Clathrin-
coated pits (CCPs) and CCVs also constitute a major route
of endocytic entry into cells [4]. Endocytosis is regulated by
the clathrin adaptor protein 2 (AP-2), a heterotetramer com-
posed of a-, b2-, l2- and r2-adaptins [3,5]. At their C-termini,
the a-, b- and c-adaptins each contain globular structures
termed ear domains. The ear domains function as recruitment
platforms that attract a diverse array of AP-binding proteins
to sites of clathrin-mediated budding [3,6,7].
Binding to the ears is mediated by short consensus peptide
motifs. The ﬁrst of these to be characterized were the DPF/
W and FXDXF motifs that mediate binding of endocytic
accessory proteins to the platform subdomain of the a-ear
[8–10]. More recently, we identiﬁed a novel AP-2-binding mo-
tif, WVQF, found at the C-terminus of the NECAP proteins
[11]. Variations of the WVQF sequence were subsequently*Corresponding author. Fax: +1 514 398 8106.
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nature of the motif [12,13]. Mutational analysis of the motif
has revealed a critical role for the W and F as well as a C-ter-
minal negative charge leading to its designation as the WXXF-
acidic motif [11,13–15]. Structural studies have revealed that
WXXF-acidic motifs interact with a site on the sandwich sub-
domain of the a-ear [14–16].
A ﬂurry of recent studies has also led to the identiﬁcation of
the ﬁrst c-ear-binding motif, which is responsible for the inter-
action of an array of clathrin regulatory proteins with AP-1
[7,17–22]. Mutational analysis identiﬁed a consensus sequence
for the motif, which like the WXXF-acidic motif, is based
around a hXXh core (where h is a large hydrophobic residue)
[23,24]. The ﬁrst h is generally an F although W and Y are also
allowed, whereas the second h is more tolerable of substitu-
tions [24]. The X following the ﬁrst h is restricted to a G or
an A and unlike the WXXF-acidic motif, which is always fol-
lowed by an acidic charge, the c-ear-binding motif generally
requires acidic residues N-terminal to the core [15,23,24].
The structure of the c-ear is similar to that of the sandwich
subdomain of the a-ear despite little sequence homology
[25,26]. However, the binding site for the c-ear motif is com-
posed of residues within b-sheets 4, 5, 7 and 8 and is on the
opposite side of the ear relative to the WXXF-acidic motif-
binding site on the a-ear [15,23,25,26].
Based on the characteristics of the c-ear-binding motif, we
searched the protein database and identiﬁed a protein, which
was named aftiphilin (from the Greek afti = ear, philo =
friend) [24] that contains eight potential copies of the c-
ear-binding motif. A large fragment from the N-terminus of
aftiphilin bearing these motifs was demonstrated to interact
with the c-ear in the yeast two-hybrid system [24]. In the cur-
rent study, we have characterized endogenous aftiphilin and
demonstrate that the protein is associated with the clathrin
machinery in neurons.2. Materials and methods
2.1. Antibodies and GST fusion proteins
For generation of polyclonal antibodies against aftiphilin, two pep-
tides were produced, one corresponding to the C-terminus of aftiphilin
(ELQDIHDAHGLRYQWGGSHSNKKL) and a second from the in-
sert domain of aftiphilin-1 (SGGSTLLNLDFFGPVDDSS) (see Fig.
1A). The peptides were coupled to KLH through a cysteine residue
added at the N-terminus and were injected into rabbits using Titermax
adjuvant (CytRx Corp.) with standard protocols. Antibody produc-
tion was monitored by Western blot of rat brain extract. A polyclonal
serum against human enthoprotin was raised in rabbits against a syn-
thetic peptide (AAHYTGDKASPDQNASTHTPQ) coupled to KLH
as described for aftiphilin peptides and a polyclonal antibody againstblished by Elsevier B.V. All rights reserved.
Fig. 1. Expression and tissue distribution of aftiphilin. (A) Motif model of aftiphilin. The eight c-ear-binding motifs are indicated by the thin black
bars and their sequence is delineated by the brackets. The ﬁrst six of these motifs are found in three clusters of two that also generate sequences
matching the consensus FXXFXXF/L, indicated by the line above the sequence. Two WXXF-acidic motifs are indicated by thicker black bars and
the insert domain is indicated in grey. (B) Post-nuclear supernatants of various tissues and (C) cell lysates were processed for Western blot with the C-
terminal antibody (aftiphilin), the insert domain antibody (aftiphilin-l), or an antibody against enthoprotin. Sk = skeletal.
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for synaptophysin was from Sigma. Clathrin-heavy chain, a-adaptin,
c-adaptin and GM130 monoclonal antibodies were from BD Trans-
duction Laboratories. For immunoﬂuorescence analysis of AP-2,
monoclonal AP6 was purchased from Aﬃnity Bioreagents. A poly-
clonal antibody for the r3-adaptin subunit of the adaptor protein 3
(AP-3) complex [28] was a gift of Dr. Victor Faundez. A polyclonal
antibody against the e-adaptin subunit of the adaptor protein 4 (AP-
4) complex was a gift of Dr. Juan Bonifacino. GST fusion proteins
encoding wild type or L762E mutant c-ear, wild type or Q782A mutant
a-ear, and wild type b2-ear were previously described [11,15,23]. The
b2-ear was a gift from Dr. Stephane Laporte.
2.2. Subcellular fractionation
CCVs were isolated from rat brain as described [17,29]. Adult rat tis-
sues and various cell lines were homogenized in buﬀer A (10 mM
HEPES-OH, pH 7.4, 0.83 mM benzamidine, 0.23 mM phenylmethyl-
sulphonyl ﬂuoride, 0.5 lg/ml aprotinin and 0.5 lg/ml leupeptin) and
centrifuged at 800 · g for 5 min. The protein content of the post-nucle-
ar supernatants was determined and equal protein aliquots were ana-
lyzed by SDS–PAGE and Western blot.
2.3. Binding assays
Rat brain was homogenized in buﬀer A containing 1% Triton X-100,
the extracts were spun in a Sorval T865 rotor at 45 000 rpm for 30 min
and the supernatant was adjusted to 1 mg/ml and 300 mM NaCl. Ali-
quots (1 ml) were incubated for 1 h at 4 C with GST fusion proteins
pre-coupled to glutathione-Sepharose. For competition pull-down as-
says, 1 mg aliquots of brain extract were incubated for 1 h at 4 C with100 pmole of GST-fusion proteins pre-coupled to glutathione-Sephar-
ose in the absence or presence of previously described synthetic pep-
tides [15,23] at a range of molar ratios relative to the fusion protein
as indicated in the ﬁgures. For immunoprecipitations, adult rat brain
was homogenized in buﬀer A with 9 strokes of a Teﬂon homogenizer.
The homogenate was centrifuged in a Sorval SS34 rotor at 2600 rpm
for 10 min and the supernatant was centrifuged in a Sorval SS34 rotor
at 10 000 rpm for 5 min. Triton X-100 was added to the resulting
supernatant to a ﬁnal concentration of 1% and the sample was centri-
fuged in a Sorval T865 rotor at 40 000 rpm for 30 min. The superna-
tant was diluted to 2 mg/ml, NaCl was added to 33 mM, and 1 ml of
extract was incubated with 20 ll of protein A-Sepharose beads. The
beads were removed and the precleared supernatant was added to pro-
tein A-Sepharose beads precoupled to the C-terminal antiserum or to
pre-immune serum from the same rabbit. The mixture was rocked
overnight at 4 C and was washed in ice cold buﬀer A with 1% Triton
X-100 and 33 mM NaCl and bound proteins were eluted in gel sample
buﬀer and were analyzed by SDS–PAGE and Western blot.2.4. Primary rat hippocampal cultures
E18-19 rat hippocampal neurons were prepared as described [30].
Cells were fed every seven days with Neurobasal medium supple-
mented with B-27, N-2, L-glutamine (500 lM) and penicillin/strepto-
mycin (100 units/ml) (Gibco), and were processed for
immunoﬂuorescence analysis or Western blot at 19–21 days in vitro.
For Western blot, cells were extracted in buﬀer A with 1% Triton X-
100. For most immunoﬂuorescence experiments, hippocampal neurons
plated on poly-L-lysine-coated coverslips were washed in phosphate
buﬀered saline (PBS; 20 mM NaH2PO4, 0.9% NaCl, pH 7.4) and ﬁxed
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PBS, incubated in PBS with 0.2% Triton X-100, washed, and incubated
in PBS with 5% normal goat serum and 5% bovine serum albumin
(BSA). Following this block, coverslips were washed in PBS and incu-
bated with primary antibodies in PBS with 1% BSA and 0.02% Triton
X-100 for 1–2 h at room temperature. For co-staining with AP-2, neu-
rons plated on poly-L-lysine-coated coverslips were processed as de-
scribed [31]. Speciﬁcally, neurons were ﬁxed in 4% paraformaldehyde
with 4% sucrose in PBS for 15 min, permeabilized with 0.25% Triton
X-100 for 5 min, and after incubation with 10% BSA for 1 h, the cells
were incubated overnight with primary antibodies in PBS with 3%
BSA at 4 C. In all cases, following incubation with primary antibod-
ies, cells were washed in PBS, incubated for 30 min at room tempera-
ture with ﬂuorescent secondary antibodies, washed, and the coverslips
were mounted on glass slides with DAKO (cytomation ﬂuorescence
mounting media; Dakocytomation) and imaged on a Zeiss 510 confo-
cal microscope. For some experiments, neurons were changed into
media containing brefeldin A (BFA; Sigma) at 100 lg/ml for 4 min
prior to ﬁxation. Quantitation of co-localization was performed using
the RG2B feature of ImageJ software, developed at the National Insti-
tute of Mental Health.Fig. 2. Aftiphilin is in complex with AP-1 and AP-2 and is present on
CCVs in brain. (A) Soluble brain extracts were incubated with the C-
terminal antibody or the corresponding pre-immune serum pre-
coupled to protein A-Sepharose. Proteins speciﬁcally bound to the
beads were processed for Western blot along with a one-tenth aliquot
of the soluble brain extract (starting material, SM) with the indicated
antibodies. (B) Equal protein aliquots of various fractions of the
enrichment procedure for CCVs from brain were processed for
Western blot with the C-terminal antibody (aftiphilin), the insert
domain antibody (aftiphilin-l), or an antibody against clathrin heavy
chain (CHC). H = homogenate, P = pellet, S = supernatant, SGs =
sucrose gradient supernatant, SGp = sucrose gradient pellet.3. Results and discussion
Aftiphilin contains eight potential c-ear-binding motifs
based around hXXh cores and in every case, h is represented
by F at both positions (Fig. 1A). Interestingly, six of the motifs
are present in three overlapping clusters of two (Fig. 1A), lead-
ing to the formation of three sequences that match a recently
described motif for a- and b2-ear binding, FXXFXXF/L [16]
(Fig. 1A). Aftiphilin also contains two sequences that match
the WXXF-acidic a-ear-binding motif (Fig. 1A). Finally, the
protein contains a 28 amino acid region that is absent in many
expressed sequence tag clones in the database suggesting that it
is encoded by a diﬀerentially utilized exon (Fig. 1A) (see also
[24]). We propose the name aftiphilin-long and -short (aftiph-
ilin-l, aftiphilin-s) for the isoform carrying or lacking this exon,
respectively. Thus far, no studies have examined the expression
or properties of endogenous aftiphilin.
We generated two antibodies, one against a peptide from the
C-terminus, common to both isoforms, the second against a
sequence from the insert domain speciﬁc to aftiphilin-l. Wes-
tern blot of tissue extracts with the C-terminal antibody re-
vealed a band of approximately 170 kDa in brain and testis
(labeled aftiphilin in Fig. 1B). Aftiphilin was detected in other
non-neuronal tissues only after long exposures (data not
shown). Aftiphilin expression was also detected in cortical neu-
rons and a variety of cell lines with highest expression levels in
pheochromocytoma PC12 cells, neuroblastoma N1E-115 cells,
and C6 glioma cells (Fig. 1C). Aftiphilin-l is expressed almost
exclusively in brain with very low levels of expression in testis
and PC12 cells (Fig. 1B/C). In contrast, enthoprotin/epsinR,
an AP-1-binding protein containing two c-ear-binding motifs
[17] has a ubiquitous tissue distribution with lower levels in
neuronal tissues (Fig. 1B/C). The migratory positions of the
proteins detected by the common and aftiphilin-l antibodies
are very similar on side-by-side blots making it diﬃcult to
determine the relative expression levels of the proteins in brain
(Fig. 4A). Moreover, aftiphilin proteins are detected at
170 kDa though the predicted masses of aftiphilin-s and -l
are 99 380 and 102 139 Da, respectively. It is not uncommon
that proteins show a higher apparent molecular mass on
SDS–PAGE than predicted from their primary sequence.
For example, amphiphysin 1 runs approximately 1.6 times lar-ger than its predicted mass, similar to what is observed here for
aftiphilin [32]. In fact, cDNA clones encoding full-length GFP-
and FLAG-tagged aftiphilin-l run at approximately 170 kDa
on SDS–PAGE after adjusting for the mass of the tag (data
not shown). Together, our data demonstrate that aftiphilin-l
is expressed almost exclusively in neuronal tissue. Aftiphilin-s
also appears to be primarily neuronal although pools of
the protein are detected at low levels outside of the nervous
system.
The presence of binding sites for clathrin adaptor proteins
suggests that aftiphilin could interact with these proteins in
brain tissue. Interestingly, immunoprecipitation of aftiphilin
leads to a speciﬁc co-immunoprecipitation of AP-1 and AP-2
with no co-immunoprecipitation of the abundant brain protein
synaptophysin (Fig. 2A). Importantly, no co-immunoprecipi-
tation of the AP-3 (r3-adaptin) or AP-4 (e-adaptin) complexes
Fig. 3. Aftiphilin binds to adaptor ear domains. (A–D) Soluble brain
extracts were incubated with GST alone or GST fusion proteins
encoding wild type or mutant forms of the ear domains of a-, b2- and
c-adaptin pre-coupled to glutathione-Sepharose. Proteins speciﬁcally
bound to the beads were processed for Western blot along with a one-
tenth aliquot of the soluble brain extract (starting material, SM) with
the indicated antibodies. (A) Pull-downs with the ear domains of a-,
b2- and c-adaptin. (B) Pull-downs with a c-ear mutant in which L762
was changed to E or with wild type c-ear in the absence of peptide or in
the presence of various molar ratios (peptide to fusion protein) of a
peptide encoding a c-ear-binding motif from enthoprotin. (C) Pull-
downs with wt b2-ear in the absence or presence of various
concentrations of a peptide encoding a FXXFXXF/L-like motif from
enthoprotin. (D) Pull-downs with an a-ear mutant in which Q782 was
changed to A or with wild type a-ear in the absence of peptide or in the
presence of various molar ratios (peptide to fusion protein) of a
peptide encoding a WXXF-acidic motif from stonin 2 (W), a
FXXFXXF/L-like motif from enthoprotin (F), or both.
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action of aftiphilin with AP-1 and AP-2 (Fig. 2A). Moreover,
aftiphilin, as detected with both the C-terminal and insert anti-
body, is enriched on CCVs puriﬁed from brain extracts (Fig.
2B). These data demonstrate that aftiphilin is associated with
the clathrin machinery in neurons. Aftiphilin was not identiﬁed
in a proteomic analysis of brain CCVs [17,33]. This is likely
due to the co-migration of aftiphilin with CHC. As such, the
mass spectrometer would fail to detect aftiphilin peptides be-
cause of the abundance of CHC peptides and in fact, CHC
was the only protein detected in the 170 kDa gel slice in the
proteomics study [33]. Moreover, the co-migration of aftiphilin
with CHC makes it diﬃcult to obtain a clear Western blot sig-
nal for aftiphilin in samples that are strongly enriched for
CHC, and therefore, the enrichment of aftiphilin on CCVs
may be underestimated.
To examine AP-1 and AP-2 binding in more detail, we per-
formed aﬃnity selection experiments from brain extracts using
GST fusion proteins for various ear domains. Since the poten-
tial binding sites for adaptor ears are identical between aftiph-
ilin-s and -l, we used the insert antibody that gave stronger
signals on Western blot. As expected, aftiphilin-l binds to a-,
b2- and c-adaptin ear domains whereas the SH3 domain pro-
tein endophilin A1 binds to none of these proteins (Fig. 3A).
We previously generated the point mutant L762E in the c-
ear that disrupts interactions with proteins bearing c-ear-bind-
ing motifs [23]. No binding of aftiphilin-l was detected to c-ear
fusion protein carrying this point mutation (Fig. 3B). More-
over, binding to wild type c-ear was reduced in the presence
of increasing concentrations of a peptide, NGDFGDWSAF
from enthoprotin [23] that contains a c-ear-binding motif.
Thus, binding of aftiphilin to the c-ear of AP-1 appears to rely
on the predicted c-ear-binding motifs.
Aftiphilin also contains three sequences that match a con-
sensus FXXFXXF/L that has been shown to mediate binding
to an unknown site on the b2-ear [16]. We thus incubated brain
extracts with GST-b2-ear in the presence of increasing concen-
trations of a peptide, NGDFGDWSAF from enthoprotin [23]
that is similar to the FXXFXXF/L consensus. This peptide
causes a complete block of aftiphilin-l binding to the b2-ear
suggesting that aftiphilin uses one or more of its
FXXFXXF/L motifs for b2-ear binding (Fig. 3C).
To examine a-ear binding, we took advantage of a previ-
ously characterized point mutant, Q782A in the sandwich do-
main of the a-ear that disrupts interactions with proteins
bearing WXXF-acidic motifs but is structurally unaltered
[15]. Aftiphilin-l fails to bind to a GST a-ear construct bearing
this mutation, demonstrating that the sandwich domain
binding site is necessary for aftiphilin interactions (Fig.
3D). Surprisingly, however, a peptide from stonin 2,
CSNWVQFEDDTP, encoding a WXXF-acidic motif that is
known to block NECAP and stonin 2 interactions with
the a-ear [13,15], fails to compete aftiphilin-l binding (W in
Fig. 3D). The FXXFXXF/L motif has also been described as
a binding motif for the platform domain of the a-ear [16].
The enthoprotin peptide also fails to disrupt aftiphilin-l bind-
ing to the a-ear (F in Fig. 3D) although when combined,
the enthoprotin and stonin 2 peptides cause a decrease in bind-
ing (F and W in Fig. 3D). Thus, both WXXF-acidic and
FXXFXXF motifs appear to contribute to aftiphilin binding
to the a-ear binding. However, even in large molar excess of
both peptides, the a-ear retains a portion of its binding to aft-iphilin-l (Fig. 3D). This could imply the presence of a third dis-
tinct a-ear-binding sequence in aftiphilin-l and in fact, a second
class of motif that interacts with the sandwich domain of the a-
ear at a site overlapping with the site for WXXF-acidic motifs
has been proposed [16]. This would explain the strong reduc-
tion in binding seen with the Q782A as this mutant would
abolish interactions with two of the three types of motifs pres-
ent in aftiphilin. Thus, our data demonstrate that aftiphilin has
multiple interactions with the a-ear although the details of this
interaction and the exact contribution of each of its potential
motifs remain unclear. Together, the binding data demonstrate
that aftiphilin has multiple interactions with AP-1 and AP-2
ear domains.
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brane budding are recruited by the ears of the APs. For the
a-ear, since DPF/W, FXDXF and FXXFXXF/L motifs bind
to an overlapping site on the platform subdomain [8–10] and
WXXF-acidic motifs use a distinct site in the sandwich subdo-
main [11,15], proteins bearing both types of motifs, such as
adaptor associated kinase 1 (AAK1) and synaptojanin have
the potential to interact with both sites simultaneously,
increasing their aﬃnity for the adaptor [14–16]. Aftiphilin ap-
pears to have multiple modes of interaction with the a-ear and
it is possible that it uses its FXXFXXF motifs to interact with
the platform site on the a-ear while simultaneously using
WXXF-acidic motifs for interactions with the sandwich site.
Aftiphilin also appears to use FXXFXXF motifs to interact
with b2-ear suggesting a unique mode of increased adaptor
aﬃnity, the simultaneous engagement of two diﬀerent ears in
the same AP-2 complex. Together, the various motifs for inter-
action of aftiphilin with AP-2 would allow for strong AP-2
binding, consistent with the co-immunoprecipitation observed
for the two proteins. Aftiphilin also has eight sites for c-ear
binding. This is analogous to several AP-2 binding proteins,
such as epsin and Eps15, which have multiple repeats of a sin-
gle motif for the same binding site on the a-ear [34,35]. This
conﬁguration has been proposed to allow for clustering ofFig. 4. Aftiphilin co-localizes with AP-1 in hippocampal neurons. (A) Crud
were processed for Western blot with the C-terminal antibody or the insert do
containing 100 lg/ml BFA (+BFA) or media alone (control). Followin
immunoﬂuorescence with the C-terminal or insert domain aftiphilin antibo
adaptin (AP-1) or GM130. A blend of aftiphilin in red and AP-1 or GM130 inAP-2, which is necessary for the formation of a stable clathrin
coat [16] and aftiphilin could thus serve a similar role for AP-1.
Moreover, aftiphilin interacts with both AP-1 and AP-2, sug-
gesting that it functions with both of these adaptors at distinct
sites of clathrin-mediated budding.
To further examine the relationship between aftiphilin and
AP-1/AP-2, we performed localization studies in neurons.
Western blots of extracts from hippocampal cultures at 21
days in vitro detected a prominent 170 kDa protein whether
the C-terminal or insert domain antibody was used (Fig.
4A). The insert domain antibody also detected a reactive
band at approximately 100 kDa (Fig. 4A). Immunoﬂuores-
cence analysis with either antibody reveals punctate aftiphilin
staining, a portion of which co-localizes with AP-1 in a peri-
nuclear pattern likely corresponding to the TGN (Fig. 4B).
Brief treatments of cells with the fungal toxin BFA causes
the small GTPase ARF to dissociate from membranes, thus
disrupting the localization of proteins such as AP-1 that have
an ARF-dependent TGN localization [36]. Following a four-
minute BFA treatment, both AP-1 and aftiphilin loose their
peri-nuclear accumulation (Fig. 4B). In contrast, the BFA
treatment does not disrupt the peri-nuclear concentration of
GM130, a marker of the cis-Golgi network (Fig. 4B). These
results suggest that aftiphilin is localized to the TGN in ane extracts from hippocampal neurons maintained in vitro for 21 days
main antibody. (B) Hippocampal neurons were transferred into media
g a 4 min incubation, cells were ﬁxed and processed for indirect
dies. The cells were co-stained with monoclonal antibodies against c-
green is shown in the rightmost panels. The scale bar represents 10 lm.
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with AP-1.
In addition to the cell body staining, we noticed the presence
of aftiphilin positive punctae that were present throughout the
neurites and which were reminiscent of synapses (Fig. 5). Syn-
apses, most notably the presynaptic compartment are robust
sites of endocytosis and AP-2 is concentrated in presynaptic
terminals [31,33,37–39]. We therefore performed co-localiza-
tion studies of aftiphilin with synaptophysin, a synaptic vesicle
protein that is a marker of the presynaptic compartment, andFig. 5. Aftiphilin is found in synapses. Hippocampal neurons at 19–21 day
terminal aftiphilin antibody and were co-stained with monoclonal antibodie
aftiphilin in red and synaptophysin in green is shown in the rightmost panels.
is shown in the rightmost panels. The second and fourth rows are magniﬁed
point to co-localizing structures. The scale bars represent 10 lm.with AP-2. Co-localization of aftiphilin punctae with both pro-
teins was readily detectable (Fig. 5). Quantitative analysis with
ImageJ software revealed that 44% of the aftiphilin punctae
were co-localized with synaptophysin and 40% were co-local-
ized with AP-2. These results demonstrate that a pool of aft-
iphilin is present in synapses. Together, our data suggest that
aftiphilin is a component of the machinery for clathrin-medi-
ated membrane budding in neurons. The protein likely func-
tions both in co-operation with AP-1 at the TGN and in
co-operation with AP-2 at the synaptic plasma membrane. Ins in vitro were processed for indirect immunoﬂuorescence with the C-
s against synaptophysin and AP-2. For the top two rows, a blend of
For the bottom two rows, a blend of aftiphilin in green and AP-2 in red
views of the images in the ﬁrst and third rows, respectively. The arrows
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ported that aftiphilin functions in sorting of the lysosomal en-
zyme cathepsin D in non-neuronal cells in culture. It will be
important to examine if this also occurs in neurons and
whether or not aftiphilin functions in endocytosis in nerve ter-
minals. Alternatively, aftiphilin could regulate the formation
of a speciﬁc vesicle population at the TGN, which is subse-
quently transported to the synapse for the delivery of synaptic
cargo. Following fusion with synaptic membranes, aftiphilin
could regulate endocytic uptake to generate a vesicle popula-
tion for retrograde transport. Resolution of these issues awaits
further study.
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